PNA-ATP aptamer-capped doxorubicin-loaded silica nanoparticles for targeted cancer therapy. 2022

Youkabed Kazemi, and Sadegh Dehghani, and Fatemeh Soltani, and Khalil Abnous, and Mona Alibolandi, and Seyed Mohammad Taghdisi, and Mohammad Ramezani
Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.

Nanomaterial-based drug delivery has opened new horizons in cancer therapy. This study aimed to investigate the in vitro and in vivo anti-cancer effects of a hyaluronic acid (HA)-targeted nanocarrier based on hollow silica nanoparticles (HSNPs), gated with peptide nucleic acid (PNA) and ATP aptamer (ATPApt) and loaded with doxorubicin (DOX). After formulation of a smart drug delivery nanosystem (HSNPs/DOX/ATPApt/PNA/HA), drug release, cytotoxicity, uptake, and in vivo anti-tumor properties were studied. Drug release test showed the controlled release of encapsulated DOX in response to ATP content. MTT and flow cytometry indicated that HA could improve both cytotoxicity and cellular uptake of the formulation. Moreover, HA-targeted formulation enhanced both the survival rate and tumor inhibition in the tumor-bearing mice compared with free DOX (P < 0.05). Our findings confirmed that HA-targeted nanoformulation, gated with PNA/aptamer and loaded with DOX can provide a novel therapeutic platform with great potential for cancer therapy.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D006820 Hyaluronic Acid A natural high-viscosity mucopolysaccharide with alternating beta (1-3) glucuronide and beta (1-4) glucosaminidic bonds. It is found in the UMBILICAL CORD, in VITREOUS BODY and in SYNOVIAL FLUID. A high urinary level is found in PROGERIA. Amo Vitrax,Amvisc,Biolon,Etamucine,Healon,Hyaluronan,Hyaluronate Sodium,Hyvisc,Luronit,Sodium Hyaluronate,Acid, Hyaluronic,Hyaluronate, Sodium,Vitrax, Amo
D000255 Adenosine Triphosphate An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter. ATP,Adenosine Triphosphate, Calcium Salt,Adenosine Triphosphate, Chromium Salt,Adenosine Triphosphate, Magnesium Salt,Adenosine Triphosphate, Manganese Salt,Adenylpyrophosphate,CaATP,CrATP,Manganese Adenosine Triphosphate,MgATP,MnATP,ATP-MgCl2,Adenosine Triphosphate, Chromium Ammonium Salt,Adenosine Triphosphate, Magnesium Chloride,Atriphos,Chromium Adenosine Triphosphate,Cr(H2O)4 ATP,Magnesium Adenosine Triphosphate,Striadyne,ATP MgCl2
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012822 Silicon Dioxide Transparent, tasteless crystals found in nature as agate, amethyst, chalcedony, cristobalite, flint, sand, QUARTZ, and tridymite. The compound is insoluble in water or acids except hydrofluoric acid. Silica,Aerosil,Aerosil 380,Cristobalite,Quso G-32,Quso G32,Tridymite,380, Aerosil,Dioxide, Silicon,G32, Quso,Quso G 32
D016503 Drug Delivery Systems Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity. Drug Targeting,Delivery System, Drug,Delivery Systems, Drug,Drug Delivery System,Drug Targetings,System, Drug Delivery,Systems, Drug Delivery,Targeting, Drug,Targetings, Drug
D017259 Dimaprit A histamine H2 receptor agonist that is often used to study the activity of histamine and its receptors. Dimaprit Dihydrochloride,Dimaprit Maleate (1:1),Dihydrochloride, Dimaprit
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Youkabed Kazemi, and Sadegh Dehghani, and Fatemeh Soltani, and Khalil Abnous, and Mona Alibolandi, and Seyed Mohammad Taghdisi, and Mohammad Ramezani
January 2018, Artificial cells, nanomedicine, and biotechnology,
Youkabed Kazemi, and Sadegh Dehghani, and Fatemeh Soltani, and Khalil Abnous, and Mona Alibolandi, and Seyed Mohammad Taghdisi, and Mohammad Ramezani
January 2017, International journal of nanomedicine,
Youkabed Kazemi, and Sadegh Dehghani, and Fatemeh Soltani, and Khalil Abnous, and Mona Alibolandi, and Seyed Mohammad Taghdisi, and Mohammad Ramezani
July 2013, Biomaterials,
Youkabed Kazemi, and Sadegh Dehghani, and Fatemeh Soltani, and Khalil Abnous, and Mona Alibolandi, and Seyed Mohammad Taghdisi, and Mohammad Ramezani
August 2014, Pharmaceutical biology,
Youkabed Kazemi, and Sadegh Dehghani, and Fatemeh Soltani, and Khalil Abnous, and Mona Alibolandi, and Seyed Mohammad Taghdisi, and Mohammad Ramezani
April 2018, Journal of nanoscience and nanotechnology,
Youkabed Kazemi, and Sadegh Dehghani, and Fatemeh Soltani, and Khalil Abnous, and Mona Alibolandi, and Seyed Mohammad Taghdisi, and Mohammad Ramezani
January 2023, Molecules (Basel, Switzerland),
Youkabed Kazemi, and Sadegh Dehghani, and Fatemeh Soltani, and Khalil Abnous, and Mona Alibolandi, and Seyed Mohammad Taghdisi, and Mohammad Ramezani
January 2020, International journal of nanomedicine,
Youkabed Kazemi, and Sadegh Dehghani, and Fatemeh Soltani, and Khalil Abnous, and Mona Alibolandi, and Seyed Mohammad Taghdisi, and Mohammad Ramezani
January 2018, Artificial cells, nanomedicine, and biotechnology,
Youkabed Kazemi, and Sadegh Dehghani, and Fatemeh Soltani, and Khalil Abnous, and Mona Alibolandi, and Seyed Mohammad Taghdisi, and Mohammad Ramezani
February 2020, Journal of drug targeting,
Youkabed Kazemi, and Sadegh Dehghani, and Fatemeh Soltani, and Khalil Abnous, and Mona Alibolandi, and Seyed Mohammad Taghdisi, and Mohammad Ramezani
November 2017, Drug delivery,
Copied contents to your clipboard!